HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan-Martin Heldt Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

8/2014Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan-Martin Heldt Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
06/2014 - 06/2003
2Neoplasms (Cancer)
03/2013 - 11/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2014
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2014
1Squamous Cell Carcinoma of Head and Neck
03/2013

Drug/Important Bio-Agent (IBA)

3Hormones (Hormone)IBA
06/2014 - 06/2003
2Cetuximab (Erbitux)FDA Link
08/2014 - 03/2013
2ErbB Receptors (EGF Receptor)IBA
08/2014 - 03/2013
1Radioisotopes (Radionuclides)IBA
08/2014
1ferrocifenIBA
06/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
03/2013
1Estrogens (Estrogen)FDA Link
11/2006
1Estradiol (Delestrogen)FDA LinkGeneric
11/2006
1afimoxifene (hydroxytamoxifen)IBA
11/2006

Therapy/Procedure

1Therapeutics
08/2014
1Radioimmunotherapy
03/2013